Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

44.5K
Overview
44.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Starch-Based Film Coatings as a Strategy to Preserve Seed Viability during Storage.

ACS omega·2026
Same author

Spontaneous Emulsification as a Low-Energy Strategy for Designing and Optimizing Resveratrol-Loaded Nanostructured Lipid Carriers.

ACS omega·2026
Same author

Does carotenoid acylation impact micellization during in vitro digestion of lutein-loaded casein-stabilized emulsions?

Food chemistry·2025
Same author

Assessment of protein incorporation into SBA-15 particles and their structural changes.

European biophysics journal : EBJ·2025
Same author

Hybridization on DNA-Coated Ultrasmall Gold Nanoparticles (2 nm).

Chemistry (Weinheim an der Bergstrasse, Germany)·2025
Same author

Evaluation of pro-inflammatory activity and immunogenicity of an inactivated SBA-15 silica vaccine against Mycoplasma hyopneumoniae in piglets.

Veterinary immunology and immunopathology·2025

Related Experiment Video

Updated: Jul 7, 2025

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

2.6K

Ordered mesoporous silicas for potential applications in solid vaccine formulations.

Matheus C R Miranda1, Carmen M Nunes1, Luana F Santos1

  • 1Instituto de Ciências Ambientais, Químicas e Farmacêuticas, Universidade Federal de São Paulo, Diadema, SP, Brazil.

Vaccine
|December 25, 2023
PubMed
Summary

Ordered mesoporous silica (SBA-15) effectively carries antigens for vaccine development. Freeze-drying and evaporation methods preserve antigen structure and enhance immunogenicity, making SBA-15 a promising antigen carrier.

Keywords:
Bovine serum albuminSBA-15Solid vaccineVaccine adjuvant

More Related Videos

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform
06:27

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform

Published on: October 20, 2020

5.2K
Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

1.2K

Related Experiment Videos

Last Updated: Jul 7, 2025

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

2.6K
Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform
06:27

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform

Published on: October 20, 2020

5.2K
Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

1.2K

Area of Science:

  • Materials Science
  • Biotechnology
  • Nanotechnology

Background:

  • Ordered mesoporous silica (SBA-15) offers high surface area and controlled porosity, making it suitable for antigen encapsulation.
  • Developing efficient vaccine formulations requires carriers that protect antigens and enhance their immunogenicity.

Purpose of the Study:

  • To investigate the impact of freeze-drying and evaporation on the physicochemical properties and immunogenicity of BSA-SBA-15 complexes.
  • To evaluate SBA-15 as a carrier for enhancing antigen immunogenicity.

Main Methods:

  • Synthesis of BSA-SBA-15 complexes.
  • Characterization using Small Angle X-ray Scattering, Nitrogen Adsorption Isotherm, Fluorescence Spectroscopy, and Circular Dichroism.
  • Immunogenic analysis via anti-BSA IgG detection.

Main Results:

  • SBA-15 structure was preserved post-BSA incorporation, with BSA aggregating in macropores.
  • Surface area and pore volume decreased, confirming BSA encapsulation.
  • BSA's native structure and aromatic residue environment were maintained.
  • SBA-15 significantly increased BSA immunogenicity (three-fold higher than BSA alone), irrespective of drying method.

Conclusions:

  • Freeze-drying and evaporation are suitable methods for preparing BSA-SBA-15 immunogenic complexes.
  • SBA-15 enhances the immunogenic activity of encapsulated antigens.
  • SBA-15 is a promising material for developing advanced vaccine formulations.